{"id":59754,"date":"2023-11-22T10:21:32","date_gmt":"2023-11-22T01:21:32","guid":{"rendered":"https:\/\/monolith.law\/en\/?p=59754"},"modified":"2024-03-11T13:28:16","modified_gmt":"2024-03-11T04:28:16","slug":"pharmaceuticals-law-penalties","status":"publish","type":"post","link":"https:\/\/monolith.law\/en\/general-corporate\/pharmaceuticals-law-penalties","title":{"rendered":"What are the Penalties and Arrest Requirements under the 'Japanese Pharmaceutical and Medical Device Act'? Explaining Points to Avoid"},"content":{"rendered":"\n

Manufacturing companies and pharmacies dealing with pharmaceuticals and similar products routinely conduct checks in accordance with the Japanese Pharmaceutical Affairs Law. However, the regulations of this law are not limited to these businesses. The scope of these regulations is extensive, and there are cases where entities unknowingly violate the Pharmaceutical Affairs Law because they are unaware they fall within its regulatory scope.<\/p>\n\n\n\n

In this article, we will thoroughly explain the penalties for violating the Pharmaceutical Affairs Law and the key points to avoid such violations, to prevent inadvertent non-compliance with the law.<\/p>\n\n\n\n

\n
\n<\/span><\/div>\n